ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Premium IconPremium Help Menu
Índice Bovespa
135.015,89
0,21%
S&P 500
5.528,75
0,06%
US Dollar vs BRL
5,6539
-0,01%
Bitcoin
94.372,45
-0,64%
Brent Oil
64,265
-0,47%
As Melhores Corretoras Online
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Ironwood Pharmaceuticals Inc (IRWD)

  7. Ironwood Pharmaceuticals Inc (IRWD) Notícias

IRWD

Ironwood Pharmaceuticals (IRWD)

Ironwood Pharmaceuticals Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:IRWD
DataHoraFonteTítuloCódigoCompanhia
28/04/202518:29Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:IRWDIronwood Pharmaceuticals Inc
28/04/202518:27Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:IRWDIronwood Pharmaceuticals Inc
28/04/202518:27Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:IRWDIronwood Pharmaceuticals Inc
25/04/202508:18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRWDIronwood Pharmaceuticals Inc
25/04/202508:05Business WireIronwood Pharmaceuticals Reiterates Full-Year 2025 LINZESS U.S. Net Sales Guidance and Raises Adjusted EBITDA GuidanceNASDAQ:IRWDIronwood Pharmaceuticals Inc
22/04/202517:05Business WireIronwood Pharmaceuticals to Present Real-World Data at Digestive Disease Week® 2025 on Adoption of New Diagnosis Codes Among Short Bowel Syndrome Patients Who Are Dependent on Parenteral SupportNASDAQ:IRWDIronwood Pharmaceuticals Inc
14/04/202508:00Business WireIronwood Pharmaceuticals Provides Clinical and Regulatory Update on ApraglutideNASDAQ:IRWDIronwood Pharmaceuticals Inc
27/03/202517:05Business WireIronwood Pharmaceuticals Announces Receipt of Nasdaq Non-Compliance Notification Regarding Late 2024 Form 10-K FilingNASDAQ:IRWDIronwood Pharmaceuticals Inc
21/03/202517:05Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
07/03/202514:19Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:IRWDIronwood Pharmaceuticals Inc
27/02/202509:00Business WireIronwood Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Results; Achieves 2024 Financial GuidanceNASDAQ:IRWDIronwood Pharmaceuticals Inc
20/02/202518:00Business WireIronwood Pharmaceuticals to Host Fourth Quarter and Full Year 2024 Investor Update CallNASDAQ:IRWDIronwood Pharmaceuticals Inc
12/02/202523:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
07/02/202518:21Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IRWDIronwood Pharmaceuticals Inc
05/02/202520:28PR Newswire (US)Millrose Properties Set to Join S&P SmallCap 600NASDAQ:IRWDIronwood Pharmaceuticals Inc
29/01/202518:05Business WireIronwood Pharmaceuticals Initiates Apraglutide NDA Submission, Highlights Compelling New Data and Updates Corporate Structure to Position for the FutureNASDAQ:IRWDIronwood Pharmaceuticals Inc
26/11/202418:01Business WireIronwood Pharmaceuticals to Participate in the Piper Sandler 36th Annual Healthcare ConferenceNASDAQ:IRWDIronwood Pharmaceuticals Inc
14/11/202417:31Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:IRWDIronwood Pharmaceuticals Inc
13/11/202418:01Business WireIronwood Pharmaceuticals to Participate in the Jefferies London Healthcare ConferenceNASDAQ:IRWDIronwood Pharmaceuticals Inc
07/11/202419:22Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IRWDIronwood Pharmaceuticals Inc
07/11/202409:00Business WireIronwood Pharmaceuticals Reports Third Quarter 2024 ResultsNASDAQ:IRWDIronwood Pharmaceuticals Inc
28/10/202408:00Business WireOnce-Weekly Apraglutide Showed Consistent Treatment Effect Across Baseline Demographics and Disease Characteristics in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF), According to New STARS Phase III Data from Ironwood at ACG 2024NASDAQ:IRWDIronwood Pharmaceuticals Inc
24/10/202417:00Business WireIronwood Pharmaceuticals to Host Third Quarter 2024 Investor Update CallNASDAQ:IRWDIronwood Pharmaceuticals Inc
23/10/202418:04Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:IRWDIronwood Pharmaceuticals Inc
29/08/202417:01Business WireIronwood Pharmaceuticals to Participate in the 2024 Wells Fargo Healthcare ConferenceNASDAQ:IRWDIronwood Pharmaceuticals Inc
08/08/202408:00Business WireIronwood Pharmaceuticals Reports Second Quarter 2024 ResultsNASDAQ:IRWDIronwood Pharmaceuticals Inc
25/07/202417:00Business WireIronwood Pharmaceuticals to Host Second Quarter 2024 Investor Update CallNASDAQ:IRWDIronwood Pharmaceuticals Inc
30/05/202417:01Business WireIronwood Pharmaceuticals to Participate in the Jefferies Global Healthcare ConferenceNASDAQ:IRWDIronwood Pharmaceuticals Inc
21/05/202407:00Business WireIronwood Late-Breaker Oral Presentation at Digestive Disease Week® Reinforces Potential of Once-Weekly Apraglutide for Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF)NASDAQ:IRWDIronwood Pharmaceuticals Inc
09/05/202408:00Business WireIronwood Pharmaceuticals Reports First Quarter 2024 ResultsNASDAQ:IRWDIronwood Pharmaceuticals Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:IRWD

Seu Histórico Recente

LSE
SGE
The Sage
LSE
TW.
Taylor Wimpey
LSE
RR.
Rolls-royce
LSE
SMT
Scottish Mortgage Invest...
BOV
BRIV3L
ALFA INVEST ON
LSE
VEMT
Vanguardusdem
LSE
GSK
Gsk
Delayed Upgrade Clock
ADVFN Logo
Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2025 ADVFN PLC - Todos os direitos reservados

Vá sem anúncios

Assine uma experiência sem anúncios

Sem anúncios

Experimente agora

Manter os anúncios